The delay, narrowed approval, and extra study steps raise concerns about the status of and potential added requirements for other COVID vaccines.
Plaque growth can lead to a higher risk of heart attack, stroke, and other life-threatening cardiovascular events for as long as 1 year.
Post-exertional malaise, or exercise intolerance, was seen in 36% of those with long COVID.
Get weekly COVD-19 updates in your inbox.
Catch the latest episode!
Top COVID FAQs
By CIDRAP & other experts
Read all 7 reports
The authors said it's not clear if reduced severity stemmed from vaccination or from Omicron characteristics.
Rebound has also been seen in untreated people and in those who took molnupiravir, and the bottom line is treatments cut severe outcomes.
COVID-19 patients who have a stroke are more than twice as likely to die than uninfected stroke patients and are often younger and healthier, finds research presented yesterday at the Society of NeuroInterventional Surgery’s (SNIS's) 19th Annual Meeting in Toronto.
Vaccine contracts with both Moderna and Pfizer come ahead of booster dose campaigns expected to begin in September.
Though vaccine hesitancy plays a role, decreased access to vaccination sites may be another overlooked barrier, researchers suggest.
A systematic review and meta-analysis published yesterday in BMJ estimates that 5.6% of COVID-19 survivors may face long-lasting changes to their sense of smell or taste, adding to concerns about the overall burden of long COVID.
Of hospitalized COVID patients, 53% still had brain fog 13 months later.
Studies suggest the market didn't just amplify virus spread, it was the early epicenter and site of SARS-CoV-2 emergence.
Completion of a primary COVID-19 vaccination series after recovery from infection was tied to half the risk of reinfection in the pre-Omicron variant era, according to a study published today in JAMA Network Open.
More broadly protective vaccines and ones that can block transmission and infection are among the next-generation vaccine goals.
